Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.
about
Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategiesA multivalent vaccination strategy for the prevention of Old World arenavirus infection in humansReporter-Expressing, Replicating-Competent Recombinant ArenavirusesJunín virus pathogenesis and virus replicationEnvelope exchange for the generation of live-attenuated arenavirus vaccinesTargeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.RNA polymerase I-driven minigenome system for Ebola viruses.Novel approaches in anti-arenaviral drug developmentEvolution of recombinant lymphocytic choriomeningitis virus/Lassa virus in vivo highlights the importance of the GPC cytosolic tail in viral fitness.Junín virus infection activates the type I interferon pathway in a RIG-I-dependent mannerAntiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease."Viral déjà vu" elicits organ-specific immune disease independent of reactivity to self.Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNAReverse genetics approaches to combat pathogenic arenavirusesDevelopment of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity.Identification and Mechanism of Action of a Novel Small-Molecule Inhibitor of Arenavirus Multiplication.Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site-1 protease inhibitor PF-429242.Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection.Lassa virus.Lassa Virus Cell Entry via Dystroglycan Involves an Unusual Pathway of Macropinocytosis.Brain-resident memory T cells represent an autonomous cytotoxic barrier to viral infectionRole of DC-SIGN in Lassa virus entry into human dendritic cellsKinetics of protective antibodies are determined by the viral surface antigen.Reverse Genetics Approaches to Control Arenavirus.Development of live-attenuated arenavirus vaccines based on codon deoptimization of the viral glycoprotein.Myristoylation of the RING finger Z protein is essential for arenavirus buddingInhibition of the type I interferon antiviral response during arenavirus infection.Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.Replicon system for Lassa virus.Sodium hydrogen exchangers contribute to arenavirus cell entry.Efficient reverse genetics generation of infectious junin viruses differing in glycoprotein processing.Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.Development of Recombinant Arenavirus-Based Vaccines.T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells.Innate and adaptive immune control of genetically engineered live-attenuated arenavirus vaccine prototypes.A cell-based luciferase assay amenable to high-throughput screening of inhibitors of arenavirus budding.Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virusGeneration of Lymphocytic Choriomeningitis Virus Based Vaccine Vectors.Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virusStudies of Lassa Virus Cell Entry.
P2860
Q24599295-F6C54025-1198-484D-9376-2C1E7F31CB94Q24611383-132E43C3-2E15-4934-899C-2A2C44D3E7CCQ26742028-4F76688E-C652-4E4D-8AE2-4340E579D4A0Q26992011-EF35FAC7-2343-4078-B069-1B7F44905A5DQ27320211-D6697C32-5297-4738-938C-FCBD1B6FAD31Q33558767-1D77C75C-398E-46AD-97AD-A74D93437730Q33707432-8AD2DBD8-5F8A-4C92-AB93-A97A1D8ED6B3Q33779739-B15910A4-C4DB-4CBB-9F1F-E747E5EB1964Q34057974-95AA330E-E767-4DD9-9B95-08554A2601CBQ34282240-1F04F471-B17F-4148-BA8A-E38236B0AF1DQ34485294-6ADEE5A3-BF76-4D11-BA4F-69D06E66F51EQ34520218-BA8C0692-DFB3-430C-8690-2CD2D42C1DD5Q34574914-F43B6234-2B8C-4204-B4FB-8D24F34872FCQ34596958-524B81F3-95B8-4F38-9140-29F316D8939FQ35638608-AA04E83C-3FA4-4DE1-8FCC-D5EDE60D119CQ35751585-2F3B63A6-8F8D-49C6-81A9-22DA4A3D0CEDQ35774829-C9E91FCA-C305-403D-BA86-24560560B874Q35847032-DDB2212D-815D-4229-BEA4-F17ACF4E7CB1Q35919691-7F2FBCC1-8209-403C-B34C-100C7C276CA5Q37073355-B979280C-3A2C-4EC2-827B-C5A62839143AQ37179031-34FFA55C-E960-412B-8A44-F7E307325D46Q37252717-2BBFD045-3968-4C81-B242-45D0711CD255Q37532751-4CB5FFDD-D901-442E-9856-E3F961D0A297Q37543755-56311954-DB45-4D25-85AB-5437903709BAQ37546745-81E7F6AC-E013-4014-96C4-0FA9FD80DF6EQ37568060-2354ECA5-0D97-4C28-8398-2EE899A82438Q37945195-D9A9E102-8243-4147-873B-0F70C5EBF1BDQ38985001-F23CD1D8-C83B-40A6-9816-8E81D2C47CDBQ39052889-FDF1895D-2411-472A-B4A1-9A1428AF001FQ39068701-B083D9A2-5CFE-484C-AB98-8CE303F152CBQ39868272-1BFD0578-4E81-49B7-A7C5-CB589A9160C2Q39977616-D2491B02-C3B0-48E6-9970-6D3E0DD73469Q40259618-EC676873-9B1F-4CCC-AA2E-37B729F719E0Q40291652-CF8754DB-1B25-49FC-A757-F6728ACC64A9Q40355385-E81536EE-347D-425D-B47E-7A6E1C9C492EQ40407065-E80D41C5-DF66-420B-A2F6-05B0C0266233Q40423159-E1462C21-45DE-41CF-AF35-65D773D4308EQ40715549-CB686A77-F48B-4078-AD1F-82A2969D3F4FQ41847342-4861F19C-E2C0-46A2-9A72-DC3668271FA0Q41922444-0C89E9AF-D598-4B65-8BA8-C8B4EA943399
P2860
Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.
@ast
Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.
@en
type
label
Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.
@ast
Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.
@en
prefLabel
Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.
@ast
Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.
@en
P2093
P2860
P356
P1476
Recombinant lymphocytic chorio ...... stomatitis virus glycoprotein.
@en
P2093
Ana B Sanchez
Daniel D Pinschewer
Juan Carlos de la Torre
P2860
P304
P356
10.1073/PNAS.1332709100
P407
P577
2003-06-13T00:00:00Z